Results 301 to 310 of about 5,436,787 (348)
Some of the next articles are maybe not open access.
British Journal of Cancer, 1993
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Seminars in Oncology Nursing, 1990
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Radiologic Clinics of North America, 2007
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2006
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
COLOMBO, NICOLETTA +6 more
openaire +2 more sources
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
COLOMBO, NICOLETTA +6 more
openaire +2 more sources
International Journal of Gynecological Cancer, 2008
Mucinous epithelial ovarian cancer (mEOC) accounts for approximately 10% of EOCs. Patients presenting with early-stage disease have an excellent prognosis, however, those with advanced disease have a poor outcome with relative resistance to standard ovarian cancer chemotherapy.
M L, Harrison, C, Jameson, M E, Gore
openaire +2 more sources
Mucinous epithelial ovarian cancer (mEOC) accounts for approximately 10% of EOCs. Patients presenting with early-stage disease have an excellent prognosis, however, those with advanced disease have a poor outcome with relative resistance to standard ovarian cancer chemotherapy.
M L, Harrison, C, Jameson, M E, Gore
openaire +2 more sources
Discover Oncology
Ovarian cancer ranks sixth as the most common cancer and fifth as the most deadly malignancy among women worldwide. In addition, it places third among the most common gynecological cancers. Which proves that it is a significant medical problem worldwide.
Weronika Anna Jurgiel +2 more
semanticscholar +1 more source
Ovarian cancer ranks sixth as the most common cancer and fifth as the most deadly malignancy among women worldwide. In addition, it places third among the most common gynecological cancers. Which proves that it is a significant medical problem worldwide.
Weronika Anna Jurgiel +2 more
semanticscholar +1 more source
Seminars in Oncology Nursing, 2002
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources
Cancer Treatment Reviews, 2001
The treatment of ovarian cancer has evolved over the past two decades from one of palliation to one where patients can achieve prolonged remission and cure. Although prognosis remains poor, it has improved with the intervention of a multidisciplinary team and greater site specialization in the organization of cancer services.
J, Christian, H, Thomas
openaire +2 more sources
The treatment of ovarian cancer has evolved over the past two decades from one of palliation to one where patients can achieve prolonged remission and cure. Although prognosis remains poor, it has improved with the intervention of a multidisciplinary team and greater site specialization in the organization of cancer services.
J, Christian, H, Thomas
openaire +2 more sources
Current Opinion in Obstetrics and Gynecology, 1994
To reduce the mortality from ovarian cancer various studies by transvaginal color Doppler (TVCD) sonography and serum CA-125 tumor marker, alone or in combination, have been performed. Relatively poor specificities of CA-125 and transvaginal conventional sonography can be improved with the use of TVCD.
A, Kurjak, M, Predanic
openaire +2 more sources
To reduce the mortality from ovarian cancer various studies by transvaginal color Doppler (TVCD) sonography and serum CA-125 tumor marker, alone or in combination, have been performed. Relatively poor specificities of CA-125 and transvaginal conventional sonography can be improved with the use of TVCD.
A, Kurjak, M, Predanic
openaire +2 more sources
Current Treatment Options in Oncology, 2000
Epithelial ovarian cancer may appear to be confined to the ovaries or pelvis in approximately one-third of patients at exploration, but up to 30% of them will be upstaged following surgical staging. Substage and histotype are the most important prognostic factors that determine the need for adjuvant treatment.
G, Coukos, S C, Rubin
openaire +2 more sources
Epithelial ovarian cancer may appear to be confined to the ovaries or pelvis in approximately one-third of patients at exploration, but up to 30% of them will be upstaged following surgical staging. Substage and histotype are the most important prognostic factors that determine the need for adjuvant treatment.
G, Coukos, S C, Rubin
openaire +2 more sources